Global Systemic Anti-Infectives Market Growth (Status and Outlook) 2022-2028

SKU ID : LPI-20556838 | Publishing Date : 23-Mar-2022

As the global economy mends, the 2021 growth of Systemic Anti-Infectives will have significant change from previous year. According to our researcher latest study, the global Systemic Anti-Infectives market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Systemic Anti-Infectives market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Systemic Anti-Infectives market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Systemic Anti-Infectives market, reaching US$ million by the year 2028. As for the Europe Systemic Anti-Infectives landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Systemic Anti-Infectives players cover Pfizer, Sumitomo Dainippon Pharma, MSD, and Bayer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Systemic Anti-Infectives market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Injections

Tablets

Capsules & Pellets

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospital

Clinic

Drugstores

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Pfizer

Sumitomo Dainippon Pharma

MSD

Bayer

Bristol-Myers Squibb

Dechra

Alandalous

Chiatai Tianqing

Hailing Pharm

Southwest Pharmaceutical Co., Ltd.

Guangzhou Baiyunshan

Harbin Pharmaceutical Group

CSPC Pharmaceutical

North China Pharmaceutical

Sinopharm

Luoxin Pharmaceutical

CR Pharma

Duopharma Biotech Group

PT Infion Pharma

Bright-gene

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
market Reports market Reports